[Flunarizine and dihydroergotamine in the treatment of migraine in children].
We administer during 6 months in randomised way dihydroergotamine or flunarizine to 50 children affects of classical or common migraine. A significative improvement was estimated in frequency, intensity and duration of their crisis in 87% with dihydroergotamine and 79% with flunarizine, without significative differences from one to other. Dihydroergotamine was specially effective in children with vegetative lability. The secondary effects, 12% with dihydroergotamine and 20% with flunarizine, were trivial and advantageous even, without the necessity of stop the treatment in not any case.
Sección de Neuropediatría Hospital Nacional Marqués de Valdecilla, Facultad de Medicina, Universidad de Cantabria, Santander.
L
L
Lastra Martínez
J
J
Herranz Fernández
R
R
Arteaga Manjón-Cabez
D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D004087:Dihydroergotamine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005444:Flunarizine / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics*; D010290:Parents
D004087:Dihydroergotamine; D005444:Flunarizine
Flunarizina o dihidroergotamina en el tratamiento de la migraña en la infancia. Estudio randomizado de 50 pacientes.